Skip to content

Stem cell therapy based on world-leading research

Delivered with EU-GMP certified cells and strict clinical oversight.

Book consultation Locations
The independent logo caro
DI logo caro
TNW_logo 1 caro
Forbed logo caro
Business insider logo caro
Beyond Tomorrow Podcast logo caro
TechCrunch_logo 1 caro
Sky_News_logo 1 caro
sifted-logo 1 caro

Stem cell therapy based on world-leading research

Cellcolabs' mesenchymal stem cells (MSCs) are based on 25 years of research in Sweden and has been used in multiple clinical trials for various indications world-wide. Previously limited to highly specific and small-scale clinical trials, Cellcolabs Clinical is now able to provide these cells in larger scale, with the goal to treat and prevent diseases and injuries that currently lack other good options.

Whole-body delivery

In intravenous (IV) treatment, mesenchymal stem cells (MSCs) are delivered through an IV line, allowing them to circulate throughout the body and support systemic healing.

Administration:
IV infusion via a vein in the arm

Typical dose:
100 million MSCs

Eligibility:
Adults 25+, subject to medical assessment

Follow-up:
Video follow-ups at 1 and 6 months, with long-term monitoring

Price:
Starting from 27,500 USD

Targeted joint delivery

In intra-articular (IA) treatment, mesenchymal stem cells (MSCs) are injected directly into a joint, concentrating the treatment on a specific area.

Administration:
Ultrasound-guided injection into a joint

Typical dose:
50 million MSCs per joint

Eligibility:
Adults 18+

Follow-up:
Clinical follow-ups at 1, 3 and 6 months

Price:
Starting from 19,000 USD

Indications

Research and treatments with MSCs is conducted on various indications. Cellcolabs Clinical provides treatments and collaborates with various clinics to enable access of Cellcolabs' MSCs. Treatments are provided within or outside clininical trials depending on region and regulatory framework.

Indications
Our locations

Globally, we are shaping the next era of responsible stem cell therapy through aligned oversight and shared scientific standards.

Explore locations
Our production

Manufactured in Sweden.
Delivered worldwide.

Every Cellcolabs Clinical dose begins in our EU-GMP certified facility in Sweden and is safeguarded through GDP-regulated transport. Across all clinics, physicians follow one unified global protocol. The result is consistent quality and clinically responsible care wherever treatment is delivered.

Learn more
Our Partners

"With GMP-certified allogeneic MSCs, for the first time we can provide patients with what autologous therapies lack: consistency and predictability"

Dr. Rikin Patel

DrRikinPatel_1
Personal guidance

Start your journey with a complimentary consultation.

Book now